公开(公告)号：EP1389200A1

公开(公告)日：2004-02-18

申请号：EP02725194.1

申请日：2002-03-15

申请人： Merck & Co., Inc.

发明人： DOHERTY, George ,  LIN, Linus, S. ,  HAGMANN, William, K. ,  KAMENECKA, Theodore, M. ,  YANG, Ginger Xu-Qiang ,  CHANG, Linda, L. ,  SHAH, Shrenik, K. ,  MUMFORD, Richard, A.

IPC分类号： C07D401/02 ,  A61K31/44

CPC分类号： C07D401/12 ,  C07D401/14

摘要： Compounds of formula (I) are antagonists of VLA-4 and/or alpha4/beta7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of AIDS-related dementia, allergic conjunctivitis, allergic rhinitis, Alzheimer's disease, asthma, atherosclerosis, autologous bone marrow transplantation, certain types of toxic and immune-based nephritis, contact dermal hypersensitivity, inflammatory bowel disease including ulcerative colitis and Crohn's disease, inflammatory lung diseases, inflammatory sequelae of viral infections, meningitis, multiple sclerosis, multiple myeloma, myocarditis, organ transplantation, psoriasis, pulmonary fibrosis, restenosis, retinitis, rheumatoid arthritis, septic arthritis, stroke, tumor metastasis, uveititis, and type I diabetes.